Biomea Fusion Stock Analysis

BMEA Stock  USD 6.38  0.10  1.59%   
Biomea Fusion is undervalued with Real Value of 18.44 and Target Price of 54.86. The main objective of Biomea Fusion stock analysis is to determine its intrinsic value, which is an estimate of what Biomea Fusion is worth, separate from its market price. There are two main types of Biomea Fusion's stock analysis: fundamental analysis and technical analysis.
The Biomea Fusion stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Biomea Fusion's ongoing operational relationships across important fundamental and technical indicators.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Biomea Fusion. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For information on how to trade Biomea Stock refer to our How to Trade Biomea Stock guide.

Biomea Stock Analysis Notes

About 25.0% of the company shares are held by company insiders. The book value of Biomea Fusion was currently reported as 2.1. The company recorded a loss per share of 4.01. Biomea Fusion had not issued any dividends in recent years. Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. The company was incorporated in 2017 and is headquartered in Redwood City, California. Biomea Fusion operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 72 people. For more info on Biomea Fusion please contact the company at 650 980 9099 or go to https://biomeafusion.com.

Biomea Fusion Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Biomea Fusion's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Biomea Fusion or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Biomea Fusion generated a negative expected return over the last 90 days
Biomea Fusion has high historical volatility and very poor performance
Net Loss for the year was (117.25 M) with profit before overhead, payroll, taxes, and interest of 0.
Biomea Fusion currently holds about 149.63 M in cash with (96.59 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.11.
Biomea Fusion has a frail financial position based on the latest SEC disclosures
Roughly 65.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Late-Breaker Oral Presentation Showing New Analysis from the Escalation Portion of COVALENT-111 Presented at the 1st Annual Asian Conference on Innovative Therapies for Diabetes Management

Biomea Fusion Upcoming and Recent Events

Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Biomea Fusion previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
26th of March 2024
Upcoming Quarterly Report
View
7th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
26th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Biomea Largest EPS Surprises

Earnings surprises can significantly impact Biomea Fusion's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-11-03
2021-09-30-0.39-0.43-0.0410 
2022-02-28
2021-12-31-0.45-0.51-0.0613 
2024-05-02
2024-03-31-0.99-1.09-0.110 
View All Earnings Estimates

Biomea Fusion Environmental, Social, and Governance (ESG) Scores

Biomea Fusion's ESG score is a quantitative measure that evaluates Biomea Fusion's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of Biomea Fusion's operations that may have significant financial implications and affect Biomea Fusion's stock price as well as guide investors towards more socially responsible investments.

Biomea Stock Institutional Investors

Shares
Northern Trust Corp2024-09-30
310.4 K
Walleye Trading Advisors, Llc2024-06-30
267.8 K
Woodline Partners Lp2024-06-30
236.4 K
Charles Schwab Investment Management Inc2024-09-30
208.4 K
Rock Springs Capital Management Lp2024-06-30
181.1 K
Deutsche Bank Ag2024-06-30
178.2 K
Superstring Capital Management Lp2024-06-30
167.1 K
Jane Street Group Llc2024-06-30
134.9 K
Prosight Management, Lp2024-06-30
124.4 K
Fmr Inc2024-09-30
5.4 M
Cormorant Asset Management, Llc2024-06-30
3.6 M
Note, although Biomea Fusion's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Biomea Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 227.58 M.

Biomea Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.59)(0.62)
Return On Capital Employed(0.71)(0.68)
Return On Assets(0.59)(0.62)
Return On Equity(0.69)(0.66)

Management Efficiency

Biomea Fusion has return on total asset (ROA) of (0.5638) % which means that it has lost $0.5638 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.0451) %, meaning that it created substantial loss on money invested by shareholders. Biomea Fusion's management efficiency ratios could be used to measure how well Biomea Fusion manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -0.62. The current year's Return On Capital Employed is expected to grow to -0.68. At present, Biomea Fusion's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Other Current Assets is expected to grow to about 3 M, whereas Total Assets are forecasted to decline to about 127.1 M.
Last ReportedProjected for Next Year
Book Value Per Share 4.96  2.66 
Tangible Book Value Per Share 4.96  2.67 
Enterprise Value Over EBITDA(2.64)(2.77)
Price Book Value Ratio 2.93  3.07 
Enterprise Value Multiple(2.64)(2.77)
Price Fair Value 2.93  3.07 
Enterprise Value122.1 M128.2 M
Biomea Fusion benefits from a proactive management team that anticipates market trends. Our analysis delves into how this proactive stance influences financial metrics and stock valuation.
Beta
(0.43)
Return On Assets
(0.56)
Return On Equity
(1.05)

Technical Drivers

As of the 22nd of November, Biomea Fusion shows the Downside Deviation of 4.88, risk adjusted performance of 0.0427, and Mean Deviation of 3.75. Biomea Fusion technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Biomea Fusion Price Movement Analysis

Execute Study
The output start index for this execution was nineteen with a total number of output elements of fourty-two. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. Biomea Fusion middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for Biomea Fusion. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.

Biomea Fusion Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Biomea Fusion insiders, such as employees or executives, is commonly permitted as long as it does not rely on Biomea Fusion's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Biomea Fusion insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Biomea Fusion Outstanding Bonds

Biomea Fusion issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biomea Fusion uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biomea bonds can be classified according to their maturity, which is the date when Biomea Fusion has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Biomea Fusion Predictive Daily Indicators

Biomea Fusion intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biomea Fusion stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Biomea Fusion Corporate Filings

13A
12th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
8K
31st of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
29th of October 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
F4
1st of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
27th of September 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
8K
31st of July 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
10th of July 2024
An amended filing to the original Schedule 13G
ViewVerify
F4
13th of June 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify

Biomea Fusion Forecast Models

Biomea Fusion's time-series forecasting models are one of many Biomea Fusion's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biomea Fusion's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

About Biomea Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Biomea Fusion prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biomea shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biomea Fusion. By using and applying Biomea Stock analysis, traders can create a robust methodology for identifying Biomea entry and exit points for their positions.
Last ReportedProjected for Next Year

Current Biomea Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Biomea analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Biomea analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
54.86Strong Buy9Odds
Biomea Fusion current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Biomea analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Biomea stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Biomea Fusion, talking to its executives and customers, or listening to Biomea conference calls.
Biomea Analyst Advice Details

Biomea Stock Analysis Indicators

Biomea Fusion stock analysis indicators help investors evaluate how Biomea Fusion stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Biomea Fusion shares will generate the highest return on investment. By understating and applying Biomea Fusion stock analysis, traders can identify Biomea Fusion position entry and exit signals to maximize returns.
Begin Period Cash Flow112.2 M
Total Stockholder Equity169.2 M
Capital Lease Obligations10.3 M
Property Plant And Equipment Net14.9 M
Cash And Short Term Investments176.9 M
Net Invested Capital169.2 M
Cash176.9 M
200 Day M A10.1493
50 Day M A9.4753
Net Interest Income8.9 M
Total Current Liabilities22.9 M
Investments-2.2 M
Stock Based Compensation14.1 M
Common Stock Shares Outstanding34.1 M
Free Cash Flow-100 M
Operating Income-126.1 M
Other Current Assets2.3 M
Accounts Payable6.9 M
Net Debt-166.6 M
Depreciation1.5 M
Other Operating Expenses126.1 M
Non Current Assets Total20.7 M
Liabilities And Stockholders Equity199.9 M
Non Currrent Assets Other5.9 M

Complementary Tools for Biomea Stock analysis

When running Biomea Fusion's price analysis, check to measure Biomea Fusion's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biomea Fusion is operating at the current time. Most of Biomea Fusion's value examination focuses on studying past and present price action to predict the probability of Biomea Fusion's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biomea Fusion's price. Additionally, you may evaluate how the addition of Biomea Fusion to your portfolios can decrease your overall portfolio volatility.
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio